Showing posts with label Dyspareunia. Show all posts
Showing posts with label Dyspareunia. Show all posts
Thursday, October 4, 2018

News from NAMS 2018: Interferential current relieves dyspareunia in women with Premature ovarian insufficiency

›
www.mccc.edu Women who have premature ovarian insufficiency (POI) face an array of problems including infertility, an early risk of a C...
2 comments:
Tuesday, July 24, 2018

FDA approves elagolix (Orilissa), the first and only oral treatment for endometriosis pain

›
The U.S. Food and Drug Administration (FDA) today approved ORILISSA™ (elagolix), the first and only oral gonadotropin-releasing hormon...
2 comments:
Wednesday, June 6, 2018

FDA approves Imvexxy to treat moderate to severe dyspareunia due to menopause

›
The United States Food and Drug Administration (FDA) has approved TX-004HR: IMVEXXY (estradiol vaginal inserts) for the treatment of...
3 comments:
Thursday, May 17, 2018

News from ACOG 2018: Elagolix promises long-term safety and efficacy in the treatment of Endometriosis

›
Elagolix, The first oral drug Elagolix showed promising results in the treatment of three types of pain in endometriosis reports th...
Thursday, October 5, 2017

New lower dose formulation of estradiol vaginal cream 0.003% relieves vulvovaginal atrophy.

›
getty images Low dose estradiol vaginal cream 0.003% helps in relieving symptoms of vulvovaginal atrophy (VVA) in postmenopausal wom...
11 comments:
Monday, December 19, 2016

Applicator-free novel vaginal estradiol softgel capsule promising in relieving vaginal atrophy.

›
Vagicap. Courtesy: TherapeuticsMD Vulvovaginal atrophy affects nearly half of the postmenopausal women in the United States. [1] It...
1 comment:
Thursday, January 14, 2016

Intravaginal dehydroepiandrosterone (DHEA) relieves women of postmenopausal pain, dryness and atrophy.

›
The most bothersome symptoms of menopause is moderate to severe pain due to vulvovaginal atrophy and other genitourinary symptoms cau...
1 comment: